
- Mount Sinai Doctors
Kristen Dams-O'connor, PhD
Psychology
About Me
Kristen Dams-O’Connor, Ph.D. is the Director of the Brain Injury Research Center (BIRC) of Mount Sinai, an internationally recognized program for traumatic brain injury (TBI) research and care. She is the Jack Nash Professor and Vice Chair of Research in the Department of Rehabilitation and Human Performance, and Professor of Neurology at the Icahn School of Medicine at Mount Sinai (ISMMS). She completed a BA in Neuroscience at Colgate University, a PhD at the University at Albany, and predoctoral training at the Rusk Institute at NYU. She completed postdoctoral fellowship in clinical neuropsychology and brain injury research and joined the faculty at ISMMS as an Assistant Professor in 2011.
Dr. Dams-O’Connor’s multidisciplinary program of research aims to improve long-term outcomes in individuals with TBI and repetitive head impacts sustained through sports, military service, and intimate partner violence (IPV). She leads multiple large-scale federally funded multicenter studies investigating the chronic health sequelae of TBI. The NIH-funded Late Effects of TBI (LETBI) project is a longitudinal prospective TBI brain donor program that aims to characterize the clinical phenotype and postmortem pathological signatures of post-traumatic neurodegeneration to facilitate in-vivo diagnostics. The ‘Leveraging Existing Aging Research Networks to understand associations of TBI and Alzheimer’s Disease (LEARN TBI-AD)’ project aims to harmonize data across 5 of the largest longitudinal studies of cognitive aging in the United States to investigate associations of TBI with AD and related dementias (ADRDs). The DoD-funded ENRICH Brain Health Focused Program Award spans 5 research projects investigating clinical and pathological signatures of post-traumatic neurodegeneration, psychological health decline, and suicide risk in civilians and Veterans with TBI. The NIDILRR-funded New York Traumatic Brain Injury Model System of care is one of 16 centers of excellence for TBI research and clinical care in the United States.
Dr. Dams-O’Connor has led and/or served on the Steering Committees of initiatives such as the NIH ADRD Summit (2019, 2022, 2025), the committee to develop Postmortem Neurotrauma Common Data Elements, the NIH TBI Classification and Nomenclature initiative, and she has served as a subject matter expert to the U.S. Secretary of the Army. She has authored over 200 scientific publications and is the recipient of awards for her research, mentorship, and brain injury advocacy.
Language
English
Position
PROFESSOR | Rehabilitation and Human Performance, PROFESSOR | Neuroscience, PROFESSOR | Neurology
Hospital Affiliations
- The Mount Sinai Hospital
Multi-Disciplinary Training Areas
Neuroscience [NEU]
Clinical Focus
- Brain Aneurysm
- Brain Tumor And Brain Cancer
- Cognitive-Behavioral Therapy (CBT)
- Concussion
- Dementia
- Neuropsychological testing
- Parkinson's Disease
- Stroke
- Traumatic Brain Injury
Education
BA, Colgate University
PhD, University at Albany, State University of New York
Internship, Psychology
Rusk Institute of Rehabilitation Medicine
Awards
2018
Fellow
American Congress of Rehabilitation Medicine (FACRM)
2018
Mitchell Rosenthal Award for Best Scientific Publication using the TBI Model System Database
National Institute for Independent Living and Rehabilitation Research, Washington DC.
2017
ACRM Mitchell Rosenthal Mid-Career Award
American Congress of Rehabilitation Medicine
2017
Joshua B. Cantor Scholar Award
Brain Injury Interdisciplinary Special Interest Group of the ACRM.
2016
Mitchell Rosenthal Award for Best Scientific Publication using the TBI Model System Database
National Institute for Independent Living and Rehabilitation Research, Washington DC
2015
Mitchell Rosenthal Memorial Lecture
Brain Injury Association of America, Washington DC
2014
International Brain Injury Association Early Career Investigator Award
International Brain Injury Association
Research
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Spinal neurotrauma outcomes at the “epicenter of the epicenter” of the United States COVID-19 pandemic. Bahie Ezzat, Cole Brown, Michael Lemonick, Mehek Dedhia, Hannah B. Bukzin, Diana C. Lee, Abhishek R. Mogili, Jonathan Anderson, Jueria Rahman, Kristen Dams-O’Connor, Salazar Jones, Konstantinos Margetis, Jamie S. Ullman, Kate Twelker, Zachary L. Hickman, Laura Salgado-Lopez. Discover public health
- Blood-Based Biomarkers for Improved Characterization of Traumatic Brain Injury: Recommendations from the 2024 National Institute for Neurological Disorders and Stroke Traumatic Brain Injury Classification and Nomenclature Initiative Blood-Based Biomarkers Working Group. Jeffrey J. Bazarian, Henrik Zetterberg, András Buki, Bradley A. Dengler, Ramon Diaz-Arrastia, Frederick K. Korley, Rachel Lazarus, Timothy B. Meier, Stefania Mondello, Kasey Moritz, David O. Okonkwo, Linda Papa, James B. Phillips, Jussi P. Posti, Ava M. Puccio, Stephanie Sloley, Ewout Steyerberg, Kevin K. Wang, Hibah O. Awwad, Kristen Dams-O’Connor, Adele Doperalski, Andrew I.R. Maas, Michael A. McCrea, Nsini Umoh, Geoffrey T. Manley. Journal of Neurotrauma
- Clinical Assessment on Days 1-14 for the Characterization of Traumatic Brain Injury: Recommendations from the 2024 NINDS Traumatic Brain Injury Classification and Nomenclature Initiative Clinical/Symptoms Working Group. David K. Menon, Noah D. Silverberg, Adam R. Ferguson, Thomas J. Bayuk, Shubhayu Bhattacharyay, David L. Brody, Scott A. Cota, Ari Ercole, Anthony Figaji, Guoyi Gao, Christopher C. Giza, Fiona Lecky, Rebekah Mannix, Ana Mikolić, Kasey E. Moritz, Claudia S. Robertson, Abel Torres-Espin, Spyridoula Tsetsou, John K. Yue, Hibah O. Awad, Kristen Dams-O’Connor, Adele Doperalski, Andrew I.R. Maas, Michael A. McCrea, Nsini Umoh, Geoffrey T. Manley. Journal of Neurotrauma
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Dams-O'Connor during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Offit Kurman Attorneys at Law
- Cody Warner PC
- Cohen & Green PLLC
- Brownstone Law Group
- MINDSET
- Goldblatt and Associates
Outside Employment
- Tampa VA Research Foundation
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.